Abstract
Introduction

56
The vascular endothelium plays a critical role in the regulation of blood pressure and 
Measurements of SKA-31 Concentration in Plasma
172
Blood samples (~2 ml) were taken via a catheter inserted into the left external jugular 
Results
195
Seven anesthetized, juvenile pigs were acutely implanted with blood pressure transducers
196
and Doppler flow probes that allowed us to measure mean aortic and inferior vena cava 197 pressures, systemic conductance and regional conductance in carotid, renal and coronary arteries.
198
Myocardial performance was monitored via a single lead electrocardiogram and implanted 199 sonomicrometry crystals in the myocardium to assess LV dimensions. Table 1 and this change was comparable to that measured following infusion of 5.0 mg/ml/kg SKA-31.
221
As quantified in Figure 3 , the time to peak response for the SKA-31 induced decrease in resistance. SKA-31 at the highest dosage decreased SVR to a level comparable to that evoked by 237 5.0 g/ml/kg SNP. Predictably, the inverse relationships were observed for drug-induced 238 changes in systemic conductance (Fig. 5B) .
239
In addition to its impact on systemic conductance, we also examined the effect of SKA- blunted compared with carotid and coronary vessels (Fig. 1C) . 
Cardiac Function
252
As depicted in Figure 7A , infusions of SKA-31 and SNP did not produce significant and SNP for the 7 animals employed in our study. In a separate group of 3 anesthetized and instrumented animals, we analyzed the plasma conscious dogs. We also noted that the decrease in mP AO evoked by 5.0 mg/ml/kg SKA-31 was 300 more rapid compared with SNP (Fig. 3) , even though both agents lowered mean aortic pressure 301 to a similar extent (Fig. 2) 
307
SKA-31 had no significant effect on mean inferior vena cava pressure (mP IVC ) (Fig. 4) 
316
SKA-31 dosages of 1.0 to 5.0 mg/ml/kg increased systemic arterial conductance, with the 317 highest dose producing an increase in conductance similar to that induced by SNP ( Figure 5B ).
318
We also observed increases in both carotid and coronary arterial conductances at 3.0 and 5.0 that renal arteries are sensitive to nitrovasodilators [20, 21] . The renal microcirculation is known 323 to exhibit strong autoregulatory behavior [22, 23] , which is critical for ensuring adequate blood is that the renal circulation may have already been near-maximally dilated, due to a combination 327 of intrinsic autoregulation and the somewhat lower mP AO present in our anesthetized pigs.
328
Alternatively, it is possible that reduced arterial resistance triggered an increase in peripheral 329 sympathetic tone to counteract reduced blood pressure, which then limited renal arterial dilation.
330
However, this possibility is less likely, as we observed no concomitant increase in heart rate with 331 declines in mP AO , which one would anticipate with the activation of a baroreceptor feedback 332 mechanism acting on the heart. providing autonomic nerve input to the heart) versus our anesthetized, instrumented pig model.
346
Importantly, the absence of SKA-31 induced changes in HR observed in our study strongly
347
suggests that plasma levels of SKA-31 sufficient to evoke substantial decreases in blood pressure 348 do not directly impact either pacemaker function or action potential propagation in the heart, as 349 revealed under conditions of minimal baroreceptor reflex activity.
350
Neither SKA-31 nor SNP significantly reduced central venous pressure (Fig. 4) . One SKA-31 and SNP administrations, and the balance of these two effects would tend to maintain 365 stroke volume near control levels in the presence of either SKA-31 or SNP (Fig. 7A ).
366
Our attempt to explore the pharmacokinetic behavior of SKA-31 revealed that its plasma 
